Design Therapeutics Income Statement (2020-2026) | DSGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & Cost
Revenue (Quarter)
Interest income
Interest Income - Total (Quarter)												0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Interest expenses
Interest Expenses (Quarter)	0.00B	0.00B		0.00B	0.00B	0.00B	10.53B	0.00B	0.00B	0.00B	1.12B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Interest Income - Net (Quarter)												0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B
Operating Items
Research & Development (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.01B	-0.05B	0.01B
Wages, Salaries and Other (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Selling, General & Administrative (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.01B
Other Operating Expenses (Quarter)																		0.00B	0.06B
Operating Expenses (Quarter)	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B
Operating Income (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
EBIT (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
Non-operating items
Interest & Investment Income (Quarter)	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non Operating Income (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Net income details
EBT (Quarter)	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-10.55B	-0.02B	-0.02B	-0.02B	-1.12B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
Profit After Tax (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
Income from Continuing Operations (Quarter)	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-10.55B	-0.02B	-0.02B	-0.02B	-1.12B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
Consolidated Net Income (Quarter)	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-10.55B	-0.02B	-0.02B	-0.02B	-1.12B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
Income towards Parent Company (Quarter)	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-10.55B	-0.02B	-0.02B	-0.02B	-1.12B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
Net Income towards Common Stockholders (Quarter)	-0.01B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-10.55B	-0.02B	-0.02B	-0.02B	-1.12B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B
Additional items
EPS (Basic) (Quarter)	-0.23	-0.29	-0.25	-0.28	-0.39	-0.44	-189.42	-0.44	-0.44	-0.35	-20.03	-0.24	-0.25	-0.27	-0.29	-0.36	-0.38	-0.34	-0.32	-0.34
EPS (Diluted) (Quarter)	-0.23	-0.29	-0.25	-0.28	-0.39	-0.44	-189.42	-0.44	-0.44	-0.35	-20.03	-0.24	-0.25	-0.27	-0.29	-0.36	-0.38	-0.34	-0.32	-0.34
Shares Outstanding (Quarter)	0.06B	0.06B	0.05B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B
Shares Outstanding (Diluted) (Quarter)	0.06B	0.06B	0.05B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B	0.06B
EBITDA (Quarter)	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B	-0.02B

Research Tools

Developers

Design Therapeutics Income Statement (2020-2026) | DSGN

Research Tools

Developers

Design Therapeutics Income Statement (2020-2026) | DSGN

Create an account

Sign In

Reset Password